How it works:
Lenvatinib is a tyrosine kinase inhibitor that blocks blood vessel formation in tumors and slows cancer cell growth.
Recommended for:
Take orally as prescribed by a physician. The dosage and treatment duration depend on the condition being treated and patient’s response.
Contraindications:
Side effects: